EMD Serono’s experience and scientific discoveries in MS date back more than 20 years. Through our disease-awareness efforts and our treatment portfolio, we understand that it’s not just the physical symptoms to contend with, but the emotional and practical implications of living with a degenerative disease. We work collaboratively with PwMS, caregivers, academia, and other members of the MS community to gain a better understanding of their experiences while living with MS and/or caring for someone with this disease.

The diagnosis and treatment journey can be challenging for people living with MS. Our sustained foundation in neurology guides us to the goal of understanding the overall challenges and needs of PwMS, as well as foster debate amongst the MS community in an effort to improve care outcomes.

We are committed to understanding the journey people living with MS face and delivering meaningful solutions that help address therapeutic needs of individual patients.

MAVENCLAD^® (cladribine) tablets 10mg

• Learn more on MAVENCLAD.com
• Please click here to see full prescribing information, including the boxed warning on risk of malignancy and teratogenicity (PDF)
  
• Medication Guide (PDF)

Rebif^® (interferon beta-1a) subcutaneous injection

• Learn more on Rebif.com
• Full Prescribing Information (PDF)
• Medication Guide (PDF)

With our history in neurology and leadership as a science-driven organization, we are deepening our commitment to people with neurological and immunological diseases by researching new therapeutic options that can make a real difference in their lives.

Looking ahead, we are advancing our R&D pipeline in neurology and immunology disorders with a high unmet medical need beyond MS. Our pipeline has potential to impact treatment across multiple conditions, including myasthenia gravis and lupus.